News LadRx Corporation

Equities

LADX

US2328287071

Market Closed - OTC Markets Other stock markets 03:45:45 2024-04-26 pm EDT			5-day change	1st Jan Change
2.35 ^USD	+4.44%		+10.85%	+80.77%

Mar. 27	LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 11	Xoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for Arimoclomol	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
FDA Acceptance of Zevra's Arimoclomol NDA Filing for Niemann-Pick Disease Type C Results in XOMA Making a $1 Million Milestone Payment to LadRx	Jan. 12	AQ
Xoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for Arimoclomol	Jan. 11	DJ
LadRx Issues 2024 Update to Shareholders	Jan. 09	BU
LadRx: Q3 Earnings Snapshot	Nov. 14	AQ
LadRx Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
LadRx : Modification to Rights of Security Holders - Form 8-K	23-09-11	PU
LadRx: Q2 Earnings Snapshot	23-08-14	AQ
LadRx Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Investor Presentation: July 2023	23-07-14	PU
LadRx Completes Non-Dilutive Financing Transaction for up to $11 Million with XOMA Corporation	23-06-22	BU
LadRx Announces Reverse Stock Split Effective as of May 17, 2023	23-05-18	BU
Reverse Split: 1 of 100	23-05-16	FA
LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
LadRx Announces Reverse Stock Split	23-05-10	BU
LadRx Corporation has filed an IPO in the amount of $24 million.	23-04-14	CI
LadRx Highlights Patent Issued for Its LADR Technology	23-03-27	BU
LadRx Highlights Patent Issued for Its LADR Technology	23-03-27	CI
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-20	CI
LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News LadRx Corporation

Equities

LADX

US2328287071

Summary

Filters